Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIDSVAX B/B Efficacy Trial
NCT00002441Phase 3Completed
- Sponsor
- diadexus
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of AIDSVAX B/B in human immunodeficiency virus infection (HIV), sponsored by diadexus. Status: completed.
02
Drugs
AIDSVAX B/B
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002441.